Comparison of injection pain between original and generic rocuronium

Comparison of injection pain between original and generic rocuronium - Comparison of original and generic rocuronium on injection pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030677

Enrollment

200

Registered

2018-01-05

Start date

2018-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing operations under general anesthesia, not limited to specific diseases

Interventions

We inject generic rocuronium 0.9 mg/kg into a vein after induction of general anesthesia with propofol or thiamylal. We inject original rocuronium 0.9 mg/kg into a vein after induction of general anes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo operations under general anesthesia

Exclusion criteria

Exclusion criteria: Patient with allergy of rocuronium, propofol and thiamyral Patients with neuromuscular disease Obesity patients (BMI 35 or higher)

Design outcomes

Primary

Measure	Time frame
Movement of the extremities after injecting rocuronium Perfusion index Changes of vital signs	—

Secondary

Measure	Time frame
Efficacy and the degree of side reactions of rocuronium	—

Countries

Japan

Contacts

Public ContactKazunobu Takahashi

Sapporo Medical University School of Medicine Department of Anesthesiology

takahashi.k@sapmed.ac.jp+81-11-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026